Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) are seeking to craft a compromise that members from both parties could accept. Their plan, still being ironed out, would not guarantee a specific limit on out-of-pocket costs but seeks to roll back insulin prices by barring rebate payments to pharmacy benefit managers.